Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of the miR-200 family in tumor tissue, plasma and urine of epithelial ovarian cancer patients in comparison to benign counterparts

1 Jul 2020

Abstract excerpt

OBJECTIVE: Plasma, but also urine sample could represent a simple liquid biopsy for ovarian cancer biomarker detection. The miRNA-200 family has been shown to be dysregulated in ovarian cancer. The aim of this study was to isolate three members of miR-200 family from tumor tissue, plasma and urine of high-grade serous ovarian cancer patients in comparison with samples from patients with benign ovarian tumors....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circular RNAs in diseases
Share to MicroRNA in disease regulation
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32611374
DOI: 10.1186/s13104-020-05155-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of the miR-200 family in tumor tissue, plasma and urine of epithelial ovarian cancer patients in comparison to benign counterpartsPMID 32611374Read ↗

Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic massSemantic proximity Read ↗

Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancerSemantic proximity Read ↗

Beyond circulating microRNA biomarkers: Urinary microRNAs in ovarian and breast cancer.Semantic proximity Read ↗

A novel circulating miRNA panel for non-invasive ovarian cancer diagnosis and prognosisSemantic proximity Read ↗

The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian CancerSemantic proximity Read ↗

The circulating miRNA-34a, miRNA -143 and miRNA -212 are promising biomarkers in ovarian cancerSemantic proximity Read ↗

Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian CancerSemantic proximity Read ↗

Liquid biopsy for diagnosing epithelial ovarian cancer: quantification of cell-free DNA and p53 mutational analysis.Semantic proximity Read ↗

Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancerSemantic proximity Read ↗

Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.Semantic proximity Read ↗

miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinomaSemantic proximity Read ↗

Repertoire of microRNAs in Epithelial Ovarian Cancer as Determined by Next Generation Sequencing of Small RNA cDNA LibrariesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.